Benzinga | Mar 1, 2021 04:04PM EST

Arcturus Therapeutics Q4 EPS $(1.25) Misses $(0.88) Estimate, Sales $2.24M Miss $2.36M Estimate

Arcturus Therapeutics (NASDAQ:ARCT) reported quarterly losses of $(1.25) per share which missed the analyst consensus estimate of $(0.88) by 42.05 percent. This is a 64.47 percent decrease over losses of $(0.76) per share from the same period last year. The company reported quarterly sales of $2.24 million which missed the analyst consensus estimate of $2.36 million by 5.17 percent. This is a 24.60 percent decrease over sales of $2.97 million the same period last year.